Characterization and in Vivo Immunomodulatory Effects of a Heteropolysaccharide from Rhizopogon Rubescens (tul.) Tul

Xinyue Huang,Huimin Ding,Qiuyan Wang,Shixuan Ma,Daodong Pan,Yuxing Guo,Mingxuan Tao
DOI: https://doi.org/10.1016/j.procbio.2022.10.009
IF: 4.885
2022-01-01
Process Biochemistry
Abstract:This study is the first to isolate and purify the primary polysaccharide fraction (PPRR) from Rhizopogon rubescens (Tul.) Tul using ultrasonic-assisted hot water extraction. PPRR is a heteropolysaccharide composed of glucose, galactose, fucose, rhamnose, mannose, and xylose. After preliminary structural characterization, the main chain of PPRR is -> 3)-beta-D-Glcp-(1 -> 6)-beta-D-Glcp-(1 ->. In vivo experiments showed that PPRR has significant therapeutic effects on the immune damage caused by cyclophosphamide (CPA). In a concentration range of 1-6 mg/mL, PPRR could augment the macrophage phagocytosis function and regulate the abnormal secretion of cytokines such as interleukin (IL)-2 and interferon (IFN)-gamma. Moreover, PPRR could reduce the inhibition of CPA on he-matopoiesis of bone marrow and alleviate the damage caused by CPA to the thymus and spleen. These findings suggest that PPRR has the potential to be used as an immunomodulator in the future.
What problem does this paper attempt to address?